Ioannis Tarnanas's email & phone | Altoida's Founder email
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Altoida Begins Its Journey To Use AI In Neuroscience With A $6.3M Funding Round — AI Daily - Artificial Intelligence News
Priority review for Alzheimer's diagnosis device from Altoida | S-GE
Ioannis Tarnanas | Nature Portfolio Health Community
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Altoida Partners to Test Precision Device in Detecting Parkinson's
Altoida AG - Venture Kick
Ioannis Tarnanas - Worldwebforum
EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer's and detect stroke risk - EIT Health
Ioannis Tarnanas - Worldwebforum
PDF) Evaluation of a computerised cognitive screening tool (ALTOIDA™) in a sample of community-dwelling older adults
Device to Spot Alzheimer's in Adults With Mild Dementia Noted by FDA
Ioannis Tarnanas - Worldwebforum
Alzheimer's detection platform Altoida raises $6.3M in Series A funding | MobiHealthNews
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Loop | Ioannis Tarnanas
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Jan. 14, 2020 - Altoida
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
Altoida's Alzheimer's-predicting smartphone app snags FDA breakthrough status | FierceBiotech
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
Altoida raises $6.3M to provide digital Alzheimer's biomarkers in augmented reality | FierceBiotech
